On Wednesday, in a statement, the University of Cambridge said, it aims to start clinical trials of its COVID-19 candidate in autumn. The development comes in the wake following funding to the tune of 1.9 million pounds from the British government. The approach adopted by the scientists behind the vaccine uses genetic sequences of all…